Attend this hard hitting session where Rebecca Wiedmeyer, President of Vela Consulting Group will share her experiences helping hundreds of covered entities understand and address MU 2. In addition she will provide answers to the complexity of addressing ICD 10.
Panelists:
Rebecca Wiedmeyer, President of Vela Consulting Group
Moderator:
Marc Haskelson, President, The Compliancy Group LLC.
Ashfield Pharmacovigilance is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
Uniquely focused on pharmacovigilance, we provide outsourced solutions and modified services to augment existing safety departments.
Ashfield Pharmacovigilance has a unique advantage in drug safety and pharmacovigilance due to the high level of expertise across our case managers, project managers, quality and regulatory staff and database administrators. We allow you to focus on your core business, while we partner with you to promote patient safety and product longevity. We achieve this by fostering the open exchange of ideas among organizations throughout the pharmacovigilance community.
By delivering innovative approaches to global case management, aggregate report development, literature search services, signal detection and surveillance, risk management services, safety system implementation, and medical information and call center services, Ashfield Pharmacovigilance is helping to advance the practice of pharmacovigilance on a global scale.
Founded in 2000, we were acquired by UDG Healthcare in 2012 and are proud to be part of its Ashfield division.
Ashfield Pharmacovigilance is headquartered in Research Triangle Park, North Carolina. Learn more about us at www.ashfieldhealthcare.com and follow us on Twitter, @DSA_PV and LinkedIn.
About Ashfield Healthcare
Ashfield Commercial & Medical Services is the sales, marketing and medical arm of UDG Healthcare plc. Established in the UK in 1997, the division is comprised of eight areas of expertise with a history of providing outstanding, client-focused services.
These eight areas of expertise include medical information, pharmacovigilance, healthcare communications, contract sales, market research, leadership training, market access strategy and meeting and event planning. The division consists of more than 5,500 staff in 20 countries.
About UDG Healthcare
Headquartered in Dublin, Ireland, UDG Healthcare plc is a diverse, global healthcare solutions company with interests in healthcare supply chain management, special packaging, sales and marketing and medical services for life science companies.
Find out more http://www.ashfieldhealthcare.com
U.S. healthcare providers have had different objectives when implementing the software and electronic token technology. LifeMed ID SecureReg™ software is designed to complement electronic tokens such magnetic stripe cards and Smart cards and utilizes industry standard HL7 protocol to build the communication link when needed.
Most of clinical trials are delayed because recruitment rates do not meet expectations, due to the growing complexity of protocols. North Africa possesses all the features to be an interesting area for numerous clinical trials…..
La plupart des essais cliniques sont annulés, à cause d’un taux de recrutement bas, qui ne satisfait pas les attentes. Cette baisse est due à une croissance de la complexité des projets de recherche. L’Afrique du Nord possède des atouts intéressants favorables pour le déroulement des essais cliniques…..
http://www.e-gcr.com/
At RavenTek, we help healthcare providers secure what matters most, build organizational resilience against cyberattacks and maximize provider Return On Life. We combine world-class technologies, innovative security ideas and a forward-thinking team of problem solvers and consultants to secure healthcare providers. We believe enterprise visibility and persistent, always-on security testing is the essential foundation of every cybersecurity program.
Ryan Coleman is Vice President of Healthcare Cybersecurity at RavenTek.
Ashfield Pharmacovigilance is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
Uniquely focused on pharmacovigilance, we provide outsourced solutions and modified services to augment existing safety departments.
Ashfield Pharmacovigilance has a unique advantage in drug safety and pharmacovigilance due to the high level of expertise across our case managers, project managers, quality and regulatory staff and database administrators. We allow you to focus on your core business, while we partner with you to promote patient safety and product longevity. We achieve this by fostering the open exchange of ideas among organizations throughout the pharmacovigilance community.
By delivering innovative approaches to global case management, aggregate report development, literature search services, signal detection and surveillance, risk management services, safety system implementation, and medical information and call center services, Ashfield Pharmacovigilance is helping to advance the practice of pharmacovigilance on a global scale.
Founded in 2000, we were acquired by UDG Healthcare in 2012 and are proud to be part of its Ashfield division.
Ashfield Pharmacovigilance is headquartered in Research Triangle Park, North Carolina. Learn more about us at www.ashfieldhealthcare.com and follow us on Twitter, @DSA_PV and LinkedIn.
About Ashfield Healthcare
Ashfield Commercial & Medical Services is the sales, marketing and medical arm of UDG Healthcare plc. Established in the UK in 1997, the division is comprised of eight areas of expertise with a history of providing outstanding, client-focused services.
These eight areas of expertise include medical information, pharmacovigilance, healthcare communications, contract sales, market research, leadership training, market access strategy and meeting and event planning. The division consists of more than 5,500 staff in 20 countries.
About UDG Healthcare
Headquartered in Dublin, Ireland, UDG Healthcare plc is a diverse, global healthcare solutions company with interests in healthcare supply chain management, special packaging, sales and marketing and medical services for life science companies.
Find out more http://www.ashfieldhealthcare.com
U.S. healthcare providers have had different objectives when implementing the software and electronic token technology. LifeMed ID SecureReg™ software is designed to complement electronic tokens such magnetic stripe cards and Smart cards and utilizes industry standard HL7 protocol to build the communication link when needed.
Most of clinical trials are delayed because recruitment rates do not meet expectations, due to the growing complexity of protocols. North Africa possesses all the features to be an interesting area for numerous clinical trials…..
La plupart des essais cliniques sont annulés, à cause d’un taux de recrutement bas, qui ne satisfait pas les attentes. Cette baisse est due à une croissance de la complexité des projets de recherche. L’Afrique du Nord possède des atouts intéressants favorables pour le déroulement des essais cliniques…..
http://www.e-gcr.com/
At RavenTek, we help healthcare providers secure what matters most, build organizational resilience against cyberattacks and maximize provider Return On Life. We combine world-class technologies, innovative security ideas and a forward-thinking team of problem solvers and consultants to secure healthcare providers. We believe enterprise visibility and persistent, always-on security testing is the essential foundation of every cybersecurity program.
Ryan Coleman is Vice President of Healthcare Cybersecurity at RavenTek.
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightVeeva Systems
Learn how you can reshape global ICSR reporting to deliver real-time visibility and oversight.
In this presentation we discuss:
- Challenges and approaches to safety data management and ICRS reporting
- How technology is making it easier to comply with global and regional requirements
- Considerations for incorporating affiliates into one pharmacovigilance solution
- Strategies for adopting a single multi-lingual safety solution
View the on-demand webinar here: https://bit.ly/35Pfyik
MEDRECON 2011 - Presented to 500 delegates all over India on 11th and 12th Feb 2011. Dr. G. D. Mogli appreciated and his comments are below Innovative session for the students and professional on how to attract the Hospital management towards Medical Records by presenting informations like this on paper.
Have you ever noticed how cognitive technologies are transforming the healthcare Insurance industry? Know More-
https://47billion.com/healthcare-industry/
Rhonda Buckholtz, VP with the American Association of Professional Coders, shares the results of a survey they conducted on the state of provider readiness for a 2014 ICD-10 implementation. She participated in our June Open Line Friday call. Find more here: www.
This presentation about patient portals software includes product descriptions, screenshots and user reviews on top-rated vendors featured in SoftwareAdvice.com
Why Patients Require Improved Referral Management From Their Doctors?GaryRichards30
Why are patients not happy with the existing referral management? What challenges do providers face in the existing patient referral management workflow? How can HealthViewX Patient Referral Management Solution aid? Watch to know!
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightVeeva Systems
Learn how you can reshape global ICSR reporting to deliver real-time visibility and oversight.
In this presentation we discuss:
- Challenges and approaches to safety data management and ICRS reporting
- How technology is making it easier to comply with global and regional requirements
- Considerations for incorporating affiliates into one pharmacovigilance solution
- Strategies for adopting a single multi-lingual safety solution
View the on-demand webinar here: https://bit.ly/35Pfyik
MEDRECON 2011 - Presented to 500 delegates all over India on 11th and 12th Feb 2011. Dr. G. D. Mogli appreciated and his comments are below Innovative session for the students and professional on how to attract the Hospital management towards Medical Records by presenting informations like this on paper.
Have you ever noticed how cognitive technologies are transforming the healthcare Insurance industry? Know More-
https://47billion.com/healthcare-industry/
Rhonda Buckholtz, VP with the American Association of Professional Coders, shares the results of a survey they conducted on the state of provider readiness for a 2014 ICD-10 implementation. She participated in our June Open Line Friday call. Find more here: www.
This presentation about patient portals software includes product descriptions, screenshots and user reviews on top-rated vendors featured in SoftwareAdvice.com
Why Patients Require Improved Referral Management From Their Doctors?GaryRichards30
Why are patients not happy with the existing referral management? What challenges do providers face in the existing patient referral management workflow? How can HealthViewX Patient Referral Management Solution aid? Watch to know!
The East Tennessee Clean Fuels Coalition--or ETCleanFuels--is managing or collaborating on diverse projects that are moving alt fuels into use in the transportation sector. Learn more here!
This is the one I did to welcome the families of those students I will be tutoring this academic year. All the relevant information about the school and the families' concern is displayed, everything presented from a humanistic point of view.
We feature experts Stanley Nachimsom of Nachimsom Associates and Michael Palatoni of Athena Health to review WEDI survey results and share small practice/physician update on ICD-10 implementation. Visit floridablue.com/icd-10, your complete ICD-10 resource.
ICD-10: A Payer Update with Aetna & United Health GroupFlorida Blue
Our November 2014 Open Line Friday call brings you updates from three major payers on their ICD-10 testing: Aetna, United, and Florida Blue. Follow our live tweeting of the call @FLBlue, or go to www.floridablue.com/icd-10 for a comprehensive list of resources.
What is the status on ICD-10? In this Infographic I bring you the facts you always wanted to know & 6 foundation blocks for successful ICD-10 implementation
This month we tackle the issue of the real cost to implement ICD-10 at the physician practice level. We are pleased to feature two testimonials from Harbor Oaks Eye Associates and Advance Medical of Naples, LLC. Stanley Nachimson also shares his expertise. Visit floridablue.com/icd-10 for your comprehensive list of resources.
ICD-10 Open Line Friday Meeting December 2014Florida Blue
Open Line Friday goes social as we invite two esteemed guests to our panel of experts: Joe Lavelle and Steve Sisko. They'll share how social media can help engage more providers in being educated on the issues surrounding ICD-10 implementation. Visit floridablue.com/icd-10 for a complete directory of resources.
Ben Quirk spoke to the South Florida medical group community about the impact of ICD-10 on the healthcare industry. It was a very informative talk that covered a lot of need-to-know details, including how ICD-10 relates to Meaningful Use and SNOMED.
The recent extension of the ICD-10 deadline was greeted with mixed reactions throughout the healthcare industry. Some favored an extension, while others preferred to move ahead with the change. In this webinar, we look at the pros and cons of the delay and how it will affect providers and patients. Reactions from other vendors are also presented.
This webinar covers Health Information Technology (HIT) topics that are very much on everyone's mind today. From ICD-10 and SNOMED coding to MU and PQRS regs, this webinar will fill you in on the background and details you need to know. And if you're currently using an older version of NextGen/KBM, you'll find the upgrade info on those systems especially useful. Take advantage of this free information from Quirk Healthcare Solutions.
ICD-10 Implementation for Physicians WhitepaperMarie Bunch
Many providers are operating with blinders on, completely unaware of the magnitude of the conversion and potential train wreck ahead for their reimbursement. Support your physicians through the difficult change ahead by helping them take the right steps forward to make their transition as efficient and painless as possible.
Regardless of the size of the practice, training for any implementation – especially for one as complex and far reaching as ICD-10 – can be costly and difficult to deliver. With only a year remaining to complete the transition, providers and their staff must step up to planning, training, software/system upgrades/replacements, as well as other necessary investments. ICD-10 will require a significant education investment in order to ensure accurate coding and minimize productivity loss. While large organizations may have the resources to purchase training materials or send staff to training sessions, smaller organizations may have to depend on special societies or share resources to provide the needed training.
Start the conversation with your physicians now. Help them through the transition with resources designed to get them on board with the transition now. Practice Management Institute® (PMI) is already helping practices adapt to the change with classes especially focused on the transition steps for medical offices, hosted by leading hospitals across the country. PMI’s Professional Services Department and Faculty Team is committed to providing the most up-to-date information on implementation guidelines, coding conversion steps and staff training fulfillment.
About PMI
PMI is the nation’s leading provider of continuing education for medical office professionals, with a broad curriculum of educational workshops that address the office training needs for private practice physicians. Classes are presented in leading hospitals, health care systems, and medical societies. For more than 30 years, physicians have relied on PMI to provide the latest information on managing an efficient and compliant practice.
Icd 10 remediation for provider practices – key challenges and mitigation str...Apoorv S
On October 1, 2014, the U.S. healthcare system will transition from the Ninth Edition of the International Classification of Diseases (ICD-9) set of diagnosis and inpatient procedure codes to the Tenth Edition of those code sets (ICD-10). Provider systems are impacted across the value chain due to ICD-10 remediation and significant changes are required across the value chain and provider business functions. This article focuses on the key challenges being faced by providers in their ICD-10 remediation journey and the mitigation approaches that providers can adopt to address them.
Latest ICD-10 Readiness Surveys and Testing ResultsFlorida Blue
On this Open Line Friday call with experts from Mayo Clinic, Baptist Health South Florida, Tampa General Hospital and others, we share the results of a survey Florida Blue conducted on the state of readiness for ICD-10 implementation.
Go deeper with athenahealth specialists to discover all that you need to know and some things you may not know about Meaningful Use Stage 2 and the newest government updates.
Preparation is the Key to Meaningful Use SuccessIatric Systems
To help hospitals and eligible providers navigate the changing landscape of Meaningful Use, we created an educational webcast.
This session provides valuable Meaningful Use information including:
• Recent updates from CMS
• Keys to audit preparation
• How to identify and correct gaps in your Meaningful Use plan
• How to ensure IMO data terminology mapping is completed accurately and on-time
Similar to Just the Facts- Meaningful Use Stage 2 & ICD 10 (20)
HIPAA compliance for Business Associates- The value of compliance, how to acq...Compliancy Group
HIPAA compliance for Business Associates has become critical as you deal with medical professionals. During this webinar we will explain the law and what Business Associates need to know and do and how to differentiate your firm to acquire new and maintain current clients.
In this webinar, we will discuss:
-The steps on how to become HIPAA compliant as a Business Associate
-What an effective BAA should include
-How to help existing and new healthcare clients with compliance
-Why it is important to differentiate yourself as HIPAA compliant
Healthcare IT thought leadership and practice managers continually seek ways to foster a culture of alertness when it comes to HIPAA compliance. They have the dual challenge of staying on the right side of federal regulators and stopping would-be hackers. This is especially true given the potential impact a data breach can have on their organization’s reputation and bottom line. By reflecting on 2015, it becomes clear that covered entities and business associates alike will continue to prepare to mitigate the threat of cyber-attacks and the planned ramp up of OCR Phase 2 Audits.
HIPAA compliance Tune-up for 2016 is the topic of this webinar – which will be focused on mitigation strategies Covered Entities and BA’s alike can take to minimize the risk of data breach or actions prompting an OCR Audit.
The HIPAA Security Rule sets out strict guidelines for Covered Entities to maintain electronic records of their protected health information.
Fortunately, Omnibus allows Covered Entities to share access to their ePHI to third-party experts called Business Associates, and specifically identifies cloud service providers as viable options. This webinar will review how to leverage the cloud to safeguard your organization’s ePHI, including:
· What HIPAA requires.
· How to the assess your current protection level.
· Bridging the gap between your protection level and HIPAA requirements
Business Associates: How to differentiate your organization using HIPAA compl...Compliancy Group
Vendors that provide services to health care providers and health insurers are under increasing pressure to protect confidential patient/member information and certify compliance with HIPAA. These “business associates” must comply with numerous data privacy and security requirements under HIPAA and state law, and their ability to do so is often a key factor health care companies use when selecting a vendor. To stand out and make the sale, business associates need to be able to demonstrate robust HIPAA compliance and sufficient policies, procedures and protocols to protect their client’s sensitive data. This webinar will address what business associates need to do to comply with HIPAA and how to differentiate your organization from the competition using HIPAA compliance.
Presenter: William J. Roberts, Shipman & Goodwin LLP
Business Associates: How to become HIPAA compliant, increase revenue, and gai...Compliancy Group
Since Omnibus started in 2013 Business Associates (BA) have scrambled to understand and adhere to the Federal Regulation. Though Omnibus alone was a reason for Business Associates to become compliant many realized that compliance could help differentiate their offerings. Helping the company retain and acquire new clients. Compliance is helping many BA’s open new revenue streams while increasing brand stickiness.
With the plethora of non-compliant Business Associates, Covered Entities are realizing that the best option for them is to choose a BA that is compliant to reduce their risk.
Have you ever felt confused by HIPAA’s complex regulations? Even if you are well versed in the laws, there are still many headache inducing intricacies. In this webinar, an experienced HIPAA auditor will highlight the basics of HIPAA, its regulations, what you need to know about it, and how it may affect you, especially with a new wave of HHS audits looming. The webinar is designed for HIPAA novices and experts alike, and all questions are encouraged in this interactive session.
HIPAA Compliance and Non-Business Associate Vendors - Strategies and Best Pra...Compliancy Group
HIPAA covered entities (including health care providers and health plans) and their business associates must be mindful of HIPAA compliance when working with other entities even when that other entity is not a business associate. Often, vendors have access to an organization’s premises or information systems which may result in incidental access to protected health information (PHI). For example, a cleaning service may have access to a medical records room or an IT support vendor may have remote access to employee workstations. While such incidental access to PHI does not make the vendor a business associate, an organization must ensure that its PHI is protected and that it complies with HIPAA. This webinar will address:
· Strategies for dealing with non-business associate vendors;
· Best practices to protect your organization; and
· Development of policies and model contract language.
How to prepare for OCR's upcoming phase 2 auditsCompliancy Group
Covered entities and business associates are on their toes awaiting the Phase 2 Audits from OCR. In this webinar we are highlighting the key points of what the OCR is looking for and how you should prepare. With the phase 2 audits being focused on the main sources of non-compliance in the Phase 1 Audits this could be the the webinar that saves your business!
Preparing for the unexpected in your medical practiceCompliancy Group
In the blink of an eye… it could all change. If you’re unprepared, a catastrophic event has the power to bring down your entire office. Learn about the best tax status for your business (HINT: it may not be what you think!), following Locum Tenens rules by the insurance companies, preparing for life insurance trusts, ensuring partnerships are not dissolved … and MORE!
HIPAA Compliance and Electronic Protected Health Information: Ignorance is no...Compliancy Group
How many electronic devices used in your organization store electronic Protected Health Information (ePHI)? If you work in a healthcare setting, this is not easily answered. While there has been considerable attention paid to ePHI stored on computers and networked servers, and recent attention given to portable devices like tablets and cell phones, one class of ePHI bearing technology remains rather mysterious – medical devices. This webinar shines a light on medical device data storage and introduces ePHI breach risks in direct patient care, clinical lab, and medical imaging settings. A brief case study for each setting will be presented.
How to Effectively Negotiate a Business Associate Agreement: What’s Importan...Compliancy Group
At some point, nearly all HIPAA covered entities and business associates must enter into business associate agreements (BAAs). Far too often though, entities commit one of two errors when doing so - they either sign a BAA “as is” without careful consideration of its terms or they negotiate each and every item in the agreement. The first error may result in significant costs and liability, and the second wastes time and money. This webinar will address the terms and conditions of BAAs that require your attention, and which ones you shouldn’t lose any sleep over. The webinar will give both covered entities and business associates the tools they need to identify and address BAA risks, while protecting their business and saving time and money.
Shipman & Goodwin LLP attorneys have negotiated thousands of BAAs for small providers, Fortune 500 companies and everyone in between.
So you finally completed the implementation of your EHR, now you are HIPAA compliant right? Sadly this is far from truth. Meaningful Use and HIPAA though containing some of the same requirements (Core Measure 9 and 15) are far from the same. Learn in this webinar the differences in HITECH Meaningful Use and HIPAA and how to help your organization satisfy both.
How to Increase Your Profits Using Patient Payments on File, Recurring and On...Compliancy Group
With the rise of High Deductible Insurance Plans and increased practice revenue coming directly from your patient receivables, it is extremely important for you to manage your patient receivables with a different mindset. Find out new ways to utilize billing options to reduce collection costs, increase profits and shorten the revenue cycle.
CardChoice International is the trusted advisor to both the American Medical Billing Association and the Practice Management Institute, and has partnered with healthcare organizations, to educate their members on the best methods for revenue cycle management.
Why a Risk Assessment is NOT Enough for HIPAA ComplianceCompliancy Group
A common misconception is that “A risk assessment makes me HIPAA compliant” Sadly this thought can cost your practice more than taking no action at all. A risk assessment is a requirement for HITECH under Meaningful Use Core Measure 15, but it does NOT make you HIPAA compliant. Furthermore it can enter you into the section of willful neglect and open your organization into the next level of fines.
Join industry experts to find out how you achieve Meaningful Use, HITECH and HIPAA compliance while protecting your practice. Don’t miss this webinar, it could be the biggest message you receive all year!
The must have tools to address your HIPAA compliance challengeCompliancy Group
A panel of experts from the companies that were chosen as “5 Key tools to help your organization achieve HIPAA compliance” In this webinar we will highlight ways for you and your organization to use tools to help make the task of HIPAA compliance easier and more effective.
Panelist:
Bob Grant ex HIPAA auditor and CCO of Compliancy Group LLC
Andy Nieto, Health IT Strategist at DataMotion
April Sage Director of Healthcare IT at Online Tech
Asaf Cidon CEO and co-founder of Sookasa
Daryl Glover Exec VP Strategic Initiatives of qliqSOFT
HIPAA MYTHS: HOW MUCH DO YOU KNOW? COMMON MYTHS DEBUNKED & EXPLAINEDCompliancy Group
HIPAA is a complex law with many ins and outs that requires a thorough understanding of the law and regulations. The complexity has given rise to numerous myths about what HIPAA actually does. To avoid creating unnecessary issues and frustration, hear about common issues that others encounter and learn how HIPAA will actually work in each circumstance. A good understanding of HIPAA will enable better compliance and make everyone happier.
What you need to know about Meaningful Use 2 & interoperabilityCompliancy Group
Does this describe you?
·You are constantly challenged to stay abreast of the latest information on EHR integration and HIE interoperability, Meaningful Use stages, the Direct Project, clinician and patient portals, just to name a few.
·You walk a fine line between adopting health information technology for the good it can bring patient outcomes…….and for the good incentive dollars it can mean to your organization.
·You play a key role in ensuring your organization can attest for meaningful use.
Join Andy Nieto, Health IT Strategist at DataMotion where he’ll explain the key role that interoperability plays in Meaningful Use Stage 2 attestation including:
- What does interoperability really mean
- Why you can’t ignore interoperability
- How to achieve interoperability and make it meaningful
- What you need in order to attest
U.S. legislation such as the Affordable Care Act, HIPAA and HITECH outline rules governing the appropriate use of personal health information (PHI). Unfortunately, current technologies do not adequately monitor PHI use. In particular, while electronic medical records (EMR) systems maintain detailed audit logs that record each access to PHI, the logs contain too many accesses for compliance officers to practically monitor, putting PHI at risk. In this talk I will present the explanation-based auditing system, which aims to filter appropriate accesses from the audit log so compliance officers can focus their efforts on suspicious behavior. The underlying premise of the system is that most appropriate accesses to medical records occur for valid clinical or operational reasons in the process of treating a patient, while inappropriate accesses do not. I will discuss how explanations for accesses (1) capture these clinical and operational reasons, (2) can be mined directly from the EMR database, (3) can be enhanced by filling-in frequently missing types of data, and (4) can drastically reduce the auditing burden.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Just the Facts- Meaningful Use Stage 2 & ICD 10
1. 855.85HIPAA
www.compliancygroup.com
Industry leading Education
Certified Partner Program
Please ask questions
For todays & past webinars go to:
http://compliancy-group.com/
webinar/
Get Involved.
#cgwebinar
2. Meaningful Use Stage 2
and ICD-10:
What Lies Ahead
Rebecca Wiedmeyer
CEO of Vela Consulting Group, LLC
Sponsored by:
3. CMS says:
● Measures focused on more rigorous
health information exchange (HIEs)
● Additional requirements for e-prescribing
and incorporating lab results
Meaningful Use Stage 2
4. CMS says:
● Electronic transmissions of patient care
summaries across multiple settings
● Increased patient and family engagement
Meaningful Use Stage 2
5. 17 Core objectives (opposed to 13 in MU
Stage 1)
3 of 6 Menu objectives (opposed to 5 of 10
in MU Stage 1)
=20 Total + CQM
MU Stage 2 Requirements
6. ● CPOE
● e-Prescribing
● Demographics
● Vital signs
● Smoking Status
● Clinical Decision Support
Core Measures
7. ● Ability for patients to see certain aspects
of their health record (portal or PHR)
● Protected EHR/Secure technology
● Integrated lab results
● Patient lists by conditions
Core Measures
8. ● Analytics for preventative and follow-up
care
● Patient Education materials
● Medication Reconciliation
● Summary of care per transfer or referral
● Immunization registries
● Bilateral communication tool for MDs/
patients
Core Measures
9. Example: CPOE
● 60% of Medications
● 30% of Labs
● 30% of Imaging Studies
Attestation - MDs Must Make the
Numbers for 90 days
10. Begins in 2014
Runs until 2016
Must use a certified EHR
Must complete attestation form and submit
(e.g. simply running reports will not
suffice)
Attestation
11. ● International Classification of Diseases
(ICD) has been used since 1979
● Current code set is ICD-9, consisting of
diagnosis codes (ICD-9 CM)
● In 1994, the World Health Organization
approved ICD-10.
ICD-10: History
12. ICD-10 consists of two code sets:
● ICD-10 CM codes - Diagnosis
● ICD-10 PCS codes - Procedures
In 2008, the Department of Health and
Human Services determined that the US
was ready to adopt ICD-10
ICD-10: History
13. ● Recent legislation has delayed
compliance until the end of 2015, no
firm date has been announced.
● ICD-10 compliance is a requirement for
Meaningful Use Stage 2.
ICD-10: Current State
14. ICD-9 =13,000 CM codes
ICD-10 = 68,000 CM codes
ICD-10 = 72,000 PCS codes
ICD-9 Versus ICD-10
15. ICD-9 codes are 3-5 characters in length
ICD-10 codes are 5-7 characters in length
*ICD-10 CM codes will be used in the
Inpatient and Outpatient spaces, but PCS
codes will only be used in the IP space.
ICD-9 Versus ICD-10
16. ● More specificity
● Less gratuitous procedures ordered
● Tracking and reporting for grants and
public health initiatives
● Globalization: other countries are
already using ICD-10
ICD-10: Pros
17. ● Loss of productivity
Coders, MDs, Billing, IT
● Revenue impact
Some healthcare facilities are
predicting up to a 70% revenue loss
ICD-10: Cons
18. ● Electronic system readiness - work with
vendors
● Update paper processes and content
● Communicate across organization or
clinic
Risk Mitigation
19. ● Test, test, test!
● Train and retrain staff and clinicians
● Confirm coders are certified in ICD-10
● Create and leverage a strong project plan
Risk Mitigation
20. ● Create/run reports both before and after
ICD-10 to monitor areas of weakness
● Plan for and utilize a strong support model
for the time of ICD-10 “go-live”
● Engage Legal and Compliance
● Select project “champions”
Risk Mitigation
22. www.compliancy-‐group.com
855.85
HIPAA
(855.854.4722)
The Guard:
• Intelligent web based solution designed by auditors.
• Used by over 1,000 Covered Entities and Business Associates
• Quickly and cost-effectively Achieve, Illustrate and Maintain HIPAA, HITECH,
and Omnibus Compliance.
• HIPAA Audit Guarantee
Features
• Policy & Procedure Templates Included
• Business Associate Management
• Document & Version Control
• Training & Attestations Tracking
• HIPAA Coaches to Assist every step of the way
HIPAA Education Series sponsored by: